HomeINRLF • OTCMKTS
add
Valneva SE
Nakaraang pagsara
$3.27
Sakop ng araw
$3.25 - $3.25
Sakop ng taon
$1.88 - $4.62
Market cap
529.82M USD
Average na Volume
88.00
P/E ratio
-
Dividend yield
-
Primary exchange
EPA
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (EUR) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 49.23M | 50.31% |
Gastos sa pagpapatakbo | 32.15M | 145.44% |
Net na kita | -9.23M | -115.67% |
Net profit margin | -18.75 | -110.42% |
Kita sa bawat share | -0.14 | -115.41% |
EBITDA | -2.28M | -103.21% |
Aktuwal na % ng binabayarang buwis | -19.00% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (EUR) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 152.99M | -13.39% |
Kabuuang asset | 482.24M | -4.09% |
Kabuuang sagutin | 306.99M | -2.11% |
Kabuuang equity | 175.25M | — |
Natitirang share | 153.87M | — |
Presyo para makapag-book | 2.87 | — |
Return on assets | -3.03% | — |
Return on capital | -3.80% | — |
Cash Flow
Net change in cash
| (EUR) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -9.23M | -115.67% |
Cash mula sa mga operasyon | -8.15M | 71.34% |
Cash mula sa pag-invest | -961.00K | -101.11% |
Cash mula sa financing | -5.58M | 25.14% |
Net change in cash | -15.28M | -130.22% |
Malayang cash flow | -19.68M | -198.73% |
Tungkol
Valneva SE is a French biotech company headquartered in Saint-Herblain, France, developing and commercializing vaccines for infectious diseases. It has manufacturing sites in Livingston, Scotland; Solna, Sweden, and Vienna, Austria; with other offices in France, Canada and the United States. Wikipedia
Itinatag
2013
Website
Mga Empleyado
713
